Peter M. Anderson

Peter M. Anderson

Pediatrics

9500 Euclid Avenue
Cleveland, OH 44195

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis.

Stereotactic Body Radiation Therapy for Pediatric, Adolescent, and Young Adult Patients With Osteosarcoma: Local Control Outcomes With Dosimetric Analysis.

Journal: Pediatric blood & cancer

Published: July 14, 2025

Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure.

Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre- and Post-Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure.

Journal: Pediatric blood & cancer

Published: January 27, 2025

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.

Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 02, 2024

Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic Sarcoma.

Neutrophil to Lymphocyte Ratio (NTLR) Predicts Local Control Failure and Overall Survival after Stereotactic Body Radiotherapy (SBRT) In Metastatic Sarcoma.

Journal: Research square

Published: June 19, 2023

Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report.

Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report.

Journal: Pediatric blood & cancer

Published: March 31, 2023

Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors.

Sodium fluoride (Na18F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumors.

Journal: ESMO open

Published: March 21, 2023

Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.

Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma.

Journal: Scientific reports

Published: February 10, 2023

Routine EWS Fusion Analysis in the Oncology Clinic to Identify Cancer-Specific Peptide Sequence Patterns That Span Breakpoints in Ewing Sarcoma and DSRCT.

Routine EWS Fusion Analysis in the Oncology Clinic to Identify Cancer-Specific Peptide Sequence Patterns That Span Breakpoints in Ewing Sarcoma and DSRCT.

Journal: Cancers

Published: January 18, 2023

Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227.

Current and future targeted alpha particle therapies for osteosarcoma: Radium-223, actinium-225, and thorium-227.

Journal: Frontiers in medicine

Published: August 28, 2022

Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.

Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 22, 2022

Editorial of Special Issue "Diet and Nutrition during Chemotherapy and Radiotherapy".

Editorial of Special Issue "Diet and Nutrition during Chemotherapy and Radiotherapy".

Journal: Nutrients

Published: May 19, 2022

Association between biologically effective dose and local control after stereotactic body radiotherapy for metastatic sarcoma.

Association between biologically effective dose and local control after stereotactic body radiotherapy for metastatic sarcoma.

Journal: Journal of radiosurgery and SBRT

Published: January 01, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026